Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Change in Accured Expenses (2019 - 2025)

Pulmonx has reported Change in Accured Expenses over the past 7 years, most recently at $528000.0 for Q3 2025.

  • Quarterly Change in Accured Expenses fell 27.87% to $528000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $2.1 million through Sep 2025, up 269.71% year-over-year, with the annual reading at $462000.0 for FY2024, 85.45% down from the prior year.
  • Change in Accured Expenses was $528000.0 for Q3 2025 at Pulmonx, down from $2.5 million in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $4.0 million in Q4 2024 and troughed at -$6.0 million in Q1 2024.
  • The 5-year median for Change in Accured Expenses is $1.0 million (2022), against an average of $355315.8.
  • Year-over-year, Change in Accured Expenses soared 237.32% in 2021 and then crashed 357.53% in 2022.
  • A 5-year view of Change in Accured Expenses shows it stood at $1.5 million in 2021, then skyrocketed by 58.05% to $2.4 million in 2022, then dropped by 5.53% to $2.3 million in 2023, then skyrocketed by 76.48% to $4.0 million in 2024, then plummeted by 86.72% to $528000.0 in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Change in Accured Expenses are $528000.0 (Q3 2025), $2.5 million (Q2 2025), and -$4.9 million (Q1 2025).